Why This Matters: Canada is falling behind in providing timely access to life-saving medications, but there is a critical opportunity to build a more resilient and competitive healthcare system.
Copy: Dr. Bettina Hamelin, President & CEO of Innovative Medicines Canada, outlines how Canada already ranks last among G7 countries for timely access to life-saving medications, and how recent global drug policy shifts risk making things worse. Government and industry must work together to build a more resilient and secure healthcare system that protects patients’ access to innovative medicines.